NIG
DGX icon

NFJ Investment Group’s Quest Diagnostics DGX Stock Holding History

NFJ Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-72,938
Closed -$9.7M – 315
2022
Q2 		$9.7M Sell
72,938
-104
-0.1% -$14.2K 0.23% 136
2022
Q1 		$10M Buy
73,042
+24,263
+50% +$3.38M 0.2% 153
2021
Q4 		$8.44M Sell
48,779
-43,847
-47% -$6.67M 0.15% 174
2021
Q3 		$13.5M Sell
92,626
-17,332
-16% -$2.54M 0.26% 124
2021
Q2 		$14.5M Sell
109,958
-10,969
-9% -$1.44M 0.27% 116
2021
Q1 		$15.5M Buy
+120,927
New +$14.9M 0.31% 103

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NFJ Investment Group's DGX Position: Q3 2022 in Review

NFJ Investment Group sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 72,938 shares — an estimated $9.7M sold.

NFJ Investment Group first reported a position in DGX in Q1 2021 and held it in 6 quarters. The position peaked at $15.5M in Q1 2021. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • NFJ Investment Group reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • NFJ Investment Group sold 72,938 Quest Diagnostics shares in Q3 2022, an estimated $9.7M.
  • NFJ Investment Group first reported a position in Quest Diagnostics in Q1 2021 and held it in 6 quarters.
  • NFJ Investment Group's Quest Diagnostics position peaked at $15.5M in Q1 2021.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on NFJ Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.